{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:51:00Z","timestamp":1790927460919,"version":"4.1.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1006\/exnr.2000.7624","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T15:46:56Z","timestamp":1032191216000},"page":"163-181","source":"Crossref","is-referenced-by-count":97,"title":["Dopamine Cell Degeneration Induced by Intraventricular Administration of 6-Hydroxydopamine in the Rat: Similarities with Cell Loss in Parkinson's Disease"],"prefix":"10.1006","volume":"169","author":[{"given":"Manuel","family":"Rodr\u0131\u0301guez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Barroso-Chinea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"Abdala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Obeso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s","family":"Gonz\u00e1lez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/exnr.2000.7624_RF1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1460-9568.1997.tb01360.x","article-title":"Vulnerability of midbrain dopaminergic neurons in calbindin D28k-deficient mice: Lack of evidence for neuroprotective endogenous calbindin in MPTP-treated and weaver mice","volume":"9","author":"Airaksinen","year":"1997","journal-title":"Eur. J. Neurosci."},{"key":"10.1006\/exnr.2000.7624_RF2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/BF00978370","article-title":"The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls","volume":"18","author":"Andrew","year":"1993","journal-title":"Neurochem. Res."},{"key":"10.1006\/exnr.2000.7624_RF3","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0306-4522(97)00665-9","article-title":"Atteniation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice","volume":"85","author":"Asanuma","year":"1998","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2000.7624_RF4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0006-8993(79)91001-1","article-title":"Efferent connections of the substantia nigra and ventral tegmental area in the rat","volume":"175","author":"Beckstead","year":"1979","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2000.7624_RF5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J. Neurol. Sci."},{"key":"10.1006\/exnr.2000.7624_RF6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0028-3908(86)90259-5","article-title":"Tremor at rest episodes in unilaterally 6-OHDA-induced substantia nigra lesioned rats: EEG-EMG and behavior","volume":"25","author":"Buonamici","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1006\/exnr.2000.7624_RF7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.2042-7158.1972.tb08916.x","article-title":"Enhancement of audiogenic seizure by 6-hydroxydopamine","volume":"24","author":"Bourn","year":"1972","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1006\/exnr.2000.7624_RF8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0024-3205(87)90154-8","article-title":"Undrugged rotational response in Nigro-striatal system-lesioned rats is related with the previous early response to apomorphine when repeatedly administered","volume":"41","author":"Burunat","year":"1987","journal-title":"Life Sci."},{"key":"10.1006\/exnr.2000.7624_RF9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0014-2999(88)90436-0","article-title":"Conditioning the early behavioral response in the rotational model of Parkinson's disease","volume":"145","author":"Burunat","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1006\/exnr.2000.7624_RF10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1476-5381.1972.tb07257.x","article-title":"Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: Effects of 6-hydroxydopamine","volume":"44","author":"Breese","year":"1972","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/exnr.2000.7624_RF11","first-page":"343","article-title":"Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: Relevance to neurological symtoms in clinical syndromes with reduced brain dopamine","volume":"231","author":"Breese","year":"1984","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1006\/exnr.2000.7624_RF12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0006-8993(88)91584-3","article-title":"Quinolinic acid lessions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy","volume":"450","author":"Calderon","year":"1998","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2000.7624_RF13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/cne.901440105","article-title":"Nigrostriatal and nigrothalamic fibers in the rhesus monkey","volume":"144","author":"Carpenter","year":"1972","journal-title":"J. Comp. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00428198","article-title":"Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval","volume":"85","author":"Castro","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1006\/exnr.2000.7624_RF15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0306-4522(90)90091-H","article-title":"Calbindin D-28k and parvoalbumin in the rat nervous system","volume":"35","author":"Celio","year":"1990","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2000.7624_RF16","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/S0021-9258(19)42751-8","article-title":"The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dyaliric acid, and related cytotoxic agents","volume":"249","author":"Cohen","year":"1974","journal-title":"J. Biol. Chem."},{"key":"10.1006\/exnr.2000.7624_RF17","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0028-3908(72)90073-1","article-title":"Catalepsy and circling behavior after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain","volume":"11","author":"Costall","year":"1972","journal-title":"Neuropharmacology"},{"key":"10.1006\/exnr.2000.7624_RF18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00439368","article-title":"Enhanced behavioral depressant effects of reserpine and \u03b1-methyl-tyrosine after 6-hydroxydopamine treatment","volume":"27","author":"Cooper","year":"1972","journal-title":"Psychopharmacology"},{"key":"10.1006\/exnr.2000.7624_RF19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0006-8993(98)00989-5","article-title":"Hydroxy radical production in the substantia nigra after 6-hydroxydopamine and hypoxia-reoxygenation","volume":"813","author":"Dajas-Bailador","year":"1998","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2000.7624_RF20","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/brain\/122.8.1421","article-title":"The substantia nigra of the human brain II. Nigrosomes and the nigral matrix, a compartimental organization based on calbindin D28k immunohistochemistry","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"10.1006\/exnr.2000.7624_RF21","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain II. Patterns of loss of dopamine-containing neurons in Parkinson's disease","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"10.1006\/exnr.2000.7624_RF22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-3940(86)90630-0","article-title":"The ascending projections of the dopaminergic neurons of the substantia nigra, zona reticulata: A combined retrograde tracer-immunohistochemical study","volume":"71","author":"Deutch","year":"1986","journal-title":"Neurosci. Lett."},{"key":"10.1006\/exnr.2000.7624_RF23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-3940(86)90228-4","article-title":"Preferential vulnerability of A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"68","author":"Deutch","year":"1986","journal-title":"Neurosci. Lett."},{"key":"10.1006\/exnr.2000.7624_RF24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0169-328X(98)00318-0","article-title":"Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death","volume":"64","author":"Dodel","year":"1999","journal-title":"Mol. Brain Res."},{"key":"10.1006\/exnr.2000.7624_RF25","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/225961a0","article-title":"Effects of 6-hydroxydopamine on CNS catecholamines, spontaneous motor activity and amphetamine-induced hyperactivity in rats","volume":"225","author":"Evetts","year":"1970","journal-title":"Nature"},{"key":"10.1006\/exnr.2000.7624_RF26","first-page":"271","article-title":"The pathogenesis of irreversible cell injury in ischemia","volume":"102","author":"Faber","year":"1981","journal-title":"Am. J. Pathol."},{"key":"10.1006\/exnr.2000.7624_RF27","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0306-4522(78)90119-7","article-title":"The cells of origin of nigrotectal, nigrothalamic and nigrostriatal projections in the rat","volume":"3","author":"Faull","year":"1978","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2000.7624_RF28","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1006\/exnr.2000.7624_RF29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0014-2999(88)90059-3","article-title":"Intrecerebral SCH 23390 and catalepsy in the rat","volume":"149","author":"Fletcher","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1006\/exnr.2000.7624_RF30","first-page":"209","article-title":"Early behavioural effects of intraventricular administration of 6-hydroxydopamine in rat","volume":"236","author":"Fibiger","year":"1972","journal-title":"Nature"},{"key":"10.1006\/exnr.2000.7624_RF31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0306-4522(97)00087-0","article-title":"Involvement of pallidal and nigral GABA mechanisms in the generation of tremulous jaw movements in the rats","volume":"80","author":"Finn","year":"1997","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2000.7624_RF32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1037\/h0077583","article-title":"Decreased locomotor and investigatory exploration after denervation of catecholamine terminal field in forebrain of rats","volume":"93","author":"Fink","year":"1979","journal-title":"J. Comp. Physiol. Psychol."},{"key":"10.1006\/exnr.2000.7624_RF33","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/0306-4522(79)90026-5","article-title":"Postnatal development of retinal projections in Syrian hamsters: A study using autoradiographic and anterograde degeneration techniques","volume":"4","author":"Fros","year":"1979","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2000.7624_RF34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0166-2236(92)90355-C","article-title":"The neostriatal mosaic: Multiple levels of compartmental organization","volume":"15","author":"Gerfen","year":"1992","journal-title":"Trends Neurosci."},{"key":"10.1006\/exnr.2000.7624_RF35","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1523\/JNEUROSCI.07-12-03915.1987","article-title":"The neostriatal mosaic. II. Path- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems","volume":"7","author":"Gerfen","year":"1987","journal-title":"J. Neurosci."},{"key":"10.1006\/exnr.2000.7624_RF36","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1073\/pnas.82.24.8780","article-title":"The neostriatal mosaic: Compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey","volume":"82","author":"Gerfen","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.2000.7624_RF37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0306-4522(88)90320-X","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridene-induced parkinsonian syndrome in macaca fascicularis: Which midbrain dopaminergic neurons are loss?","volume":"24","author":"German","year":"1988","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2000.7624_RF38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/cne.903310302","article-title":"Midbrain dopaminergic neurons (nuclei A8, A9 and A10): Three-dimensional reconstruction in the rat","volume":"331","author":"German","year":"1993","journal-title":"J. Comp. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ana.410260403","article-title":"Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization","volume":"26","author":"German","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF40","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jnnp.54.5.388","article-title":"Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease","volume":"54","author":"Gibb","year":"1991","journal-title":"J. Neurol. Neurosurg. Psychiat."},{"key":"10.1006\/exnr.2000.7624_RF41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0006-8993(92)90719-P","article-title":"Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease","volume":"581","author":"Gibb","year":"1992","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2000.7624_RF42","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1046\/j.1471-4159.1996.66052004.x","article-title":"Nature of inhibition of mitocondrial respiratory complex I by 6-hydroxydopamine","volume":"66","author":"Glinka","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.2000.7624_RF43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-7091-6842-4_7","article-title":"Mechanism of 6-hydroxydopamine neurotoxicity","volume":"50","author":"Glinka","year":"1997","journal-title":"J. Neural Trans. Suppl."},{"key":"10.1006\/exnr.2000.7624_RF44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-2999(98)00279-9","article-title":"Mechanism of inhibition of mitocondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine","volume":"351","author":"Glinka","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1006\/exnr.2000.7624_RF45","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1111\/j.1460-9568.1997.tb01695.x","article-title":"NOS expression in nigral cells after excitotoxic and non-excitotoxic lesion of the pedunculopontine tegmental nucleus","volume":"9","author":"Gonz\u00e1lez-Hernandez","year":"1997","journal-title":"Eur. J. Neurosci."},{"key":"10.1006\/exnr.2000.7624_RF46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/(SICI)1096-9861(20000522)421:1<107::AID-CNE7>3.0.CO;2-F","article-title":"Compartmental organization and chemical profile of dopaminergic and GABAergic neurons in the substantia nigra of the rat","volume":"421","author":"Gonz\u00e1lez-Hern\u00e1ndez","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF47","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1073\/pnas.90.13.6315","article-title":"Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo","volume":"90","author":"Hagg","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.2000.7624_RF48","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.410270405","article-title":"Neuropaphology of immunohistochemically identified brainstem neurons in Parkinson's disease","volume":"27","author":"Halliday","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF49","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0967-5868(96)90083-1","article-title":"Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease","volume":"3","author":"Halliday","year":"1996","journal-title":"J. Clin. Neurosci."},{"key":"10.1006\/exnr.2000.7624_RF50","first-page":"1","article-title":"Zur normalatomie der substantia nigra. Versuch einer architektonischen Gliederung","volume":"48","author":"Hassler","year":"1937","journal-title":"J. Psychol. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF51","first-page":"387","article-title":"Zur pathologie der paralysis agitants und des postenzephalitischen Parkinsonismus","volume":"48","author":"Hassler","year":"1938","journal-title":"J. Psychol. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF52","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0306-4522(98)00009-8","article-title":"The effects of globus pallidus lesions on dopamine-dependent motor behaviour in rats","volume":"86","author":"Hauber","year":"1998","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2000.7624_RF53","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/cne.903620308","article-title":"Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity","volume":"362","author":"Haber","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1126\/science.181.4098.456","article-title":"6-hydroxydopamine evidence for superoxide radical as an oxidative intermediate","volume":"181","author":"Heikkila","year":"1973","journal-title":"Science"},{"key":"10.1006\/exnr.2000.7624_RF55","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease","volume":"334","author":"Hirsch","year":"1988","journal-title":"Nature"},{"key":"10.1006\/exnr.2000.7624_RF56","first-page":"8393","article-title":"Expression of calbindin D28k-like immunorreactivity in catecholaminergic cell groups of the human midbrain: Normal distribution and distribution in Parkinson's disease","volume":"1","author":"Hirsch","year":"1992","journal-title":"Neurodegeneration"},{"key":"10.1006\/exnr.2000.7624_RF57","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ana.410440717","article-title":"Glial cells and inflamation in Parkinson's disease: A role in neurodegeneration?","volume":"44","author":"Hirsch","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF58","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1476-5381.1974.tb08571.x","article-title":"Effect of selective destruction of central and peripheral catecholamine-containing neurones with 6-hydroxydopamine on catecholamine excretion in the rat","volume":"50","author":"Hoeldtke","year":"1974","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/exnr.2000.7624_RF59","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF02246184","article-title":"Catalepsy as a rodent model for detecting antipsychotic drugs with extrapiramidal side effect liability","volume":"120","author":"Hoffman","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1006\/exnr.2000.7624_RF60","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0006-8993(89)90793-2","article-title":"Calbindin D28k-immunorreactive cholinergic neurons in the nucleus basalis of Meynert in Alzehimer-type dementia","volume":"499","author":"Ichimaya","year":"1998","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2000.7624_RF61","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0169-328X(94)00209-W","article-title":"Point mutations of mitochondrial genome in Parkinson's disease","volume":"28","author":"Ikebe","year":"1995","journal-title":"Mol. Brain Res."},{"key":"10.1006\/exnr.2000.7624_RF62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF00241410","article-title":"Mapping of the colocalization of calretinin and tyrosine hydroxylase in the rat substantia nigra and ventral tegmental area","volume":"99","author":"Isaacs","year":"1994","journal-title":"Exp. Brain Res."},{"key":"10.1006\/exnr.2000.7624_RF63","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1212\/WNL.30.12.1326","article-title":"Is the mesocortical dopaminergic system involved in Parkinson's disease?","volume":"30","author":"Javoy-Agid","year":"1980","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF64","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1471-4159.1981.tb04672.x","article-title":"Tyrosine hydroxylase, glutamic acid decarboxylase, and choline acetyltransferase in the substantia nigra and ventral tegmental tegmental area of control and Parkinsonian brains","volume":"37","author":"Javoy-Agid","year":"1981","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.2000.7624_RF65","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1111\/j.1471-4159.1981.tb10843.x","article-title":"Distribution of catecholamines in the ventral mesencephalon of human brain, with special reference to Parkinson's disease","volume":"36","author":"Javoy-Agid","year":"1981","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.2000.7624_RF66","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF03159935","article-title":"Pathology of Parkinson's disease. Changes other that the nigrostriatal pathway","volume":"14","author":"Jellinger","year":"1991","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1006\/exnr.2000.7624_RF67","first-page":"297","article-title":"Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease","volume":"46","author":"Jellinger","year":"1995","journal-title":"J. Neural. Transm. Suppl."},{"key":"10.1006\/exnr.2000.7624_RF68","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ana.410440712","article-title":"Understanding cell death in Parkinson's disease","volume":"44","author":"Jenner","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF69","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0006-8993(87)91650-7","article-title":"Subdivisions of the primate substantia nigra pars compacta detected by acetyl-cholinesterase histochemistry","volume":"437","author":"Jimenez-Castellanos","year":"1987","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2000.7624_RF70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0306-4522(87)90285-5","article-title":"Subdivisions of the dopamine-containing A8\u2013A9\u2013A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriasomal matrix","volume":"23","author":"Jimenez-Castellanos","year":"1987","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2000.7624_RF71","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1523\/JNEUROSCI.11-12-03822.1991","article-title":"Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to Parkinsonian symptoms","volume":"11","author":"Jicha","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1006\/exnr.2000.7624_RF72","series-title":"6-Hydroxydopamine and Catecholamine Neurons","first-page":"333","article-title":"Effect of some centrally acting agents in rats after intraventricular injections of 6-hydroxydopamine","author":"Jalfre","year":"1971"},{"key":"10.1006\/exnr.2000.7624_RF73","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1046\/j.1471-4159.1995.64041703.x","article-title":"Free radical-generated neurotoxicity by 6-hydroxydopamine","volume":"64","author":"Kumar","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.2000.7624_RF74","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF75","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","article-title":"Uneven patter of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: pathophysiologic and clinical implications","volume":"318","author":"Kish","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/exnr.2000.7624_RF76","first-page":"213","article-title":"Clioquinol and 2,5-hexanedione induced different types of distal axonopathy in the dog","volume":"47","author":"Krinke","year":"1979","journal-title":"Neuropharmacology (Berlin)"},{"key":"10.1006\/exnr.2000.7624_RF77","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0006-8993(89)91114-1","article-title":"Distinct nigrostriatal projection systems innervate striosomes and matrix in the primate striatum","volume":"498","author":"Langer","year":"1989","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2000.7624_RF78","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in human due to a product of meperidine-analog synthesis","volume":"219","author":"Langton","year":"1983","journal-title":"Science"},{"key":"10.1006\/exnr.2000.7624_RF79","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1476-5381.1970.tb10659.x","article-title":"Effects of intraventricular 2,4,5-trihydroxyphenylethylamine (6-hydroxydopamine) on rat behavior and brain catecholamine metabolism","volume":"40","author":"Laverty","year":"1970","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/exnr.2000.7624_RF80","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1471-4159.1978.tb07816.x","article-title":"Acetylcholinesterase in the substantia nigra and caudate-putamen of the rat: Properties and localization in dopaminergic neurons","volume":"30","author":"Lehmann","year":"1978","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.2000.7624_RF81","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/cne.903450407","article-title":"Primate striatonigral projections: A comparison of the sensorimotor-related striatum and the ventral striatum","volume":"345","author":"Lynd-Balta","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF82","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0091-6773(73)80061-6","article-title":"Central effects of 6-hydroxydopamine","volume":"9","author":"Longo","year":"1973","journal-title":"Behav. Biol."},{"key":"10.1006\/exnr.2000.7624_RF83","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF01244728","article-title":"The effects of 6-hydroxydopamine pretreatment on the accumulation of Dopa and dopamine in the brain and peripheral organs following L-Dopa administration","volume":"33","author":"Lytle","year":"1972","journal-title":"J. Neural. Transm."},{"key":"10.1006\/exnr.2000.7624_RF84","first-page":"59","article-title":"Cellular mechanisms underlying exitotoxicity","volume":"10","author":"Mayer","year":"1987","journal-title":"Trans. Neurosci."},{"key":"10.1006\/exnr.2000.7624_RF85","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0091-3057(96)00225-0","article-title":"Tremolous jaw movements produced by acute tacrine administration: Possible relation to parkinsonian side effects","volume":"56","author":"Mayorga","year":"1997","journal-title":"Pharm. Biochem. Behav."},{"key":"10.1006\/exnr.2000.7624_RF86","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.410240415","article-title":"Rate of cell death in parkinsonism indicate active neuropathological process","volume":"24","author":"McGeer","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF87","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/(SICI)1096-9861(19960101)364:1<121::AID-CNE11>3.0.CO;2-1","article-title":"Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans","volume":"364","author":"McRitchie","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF88","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/exnr.1997.6418","article-title":"Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease","volume":"144","author":"McRitchie","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF89","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0006-8993(94)90511-8","article-title":"Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?","volume":"668","author":"Mouatt-Prigent","year":"1994","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2000.7624_RF90","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02834244","article-title":"Dopaminergic deficiency is more pronounced in putamen than in nucleus caudatus in Parkinson's patients","volume":"1","author":"Nyberg","year":"1980","journal-title":"Neurochem. Pathol."},{"key":"10.1006\/exnr.2000.7624_RF91","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0165-0173(87)90011-7","article-title":"Ventral tegmental (A10) system: Neurobiology. 1. Anatomy and connectivity","volume":"12","author":"Oades","year":"1987","journal-title":"Brain Res. Rev."},{"key":"10.1006\/exnr.2000.7624_RF92","first-page":"1031","article-title":"Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat. 2. intracerebral microinjection of dopamine agonists and antagonists","volume":"280","author":"Okamura","year":"1997","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1006\/exnr.2000.7624_RF93","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1006\/exnr.2000.7624_RF94","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0006-8993(72)90385-X","article-title":"Heterogeneity of striatal and limbic dopamine innervation: Highly fluorescent islands in developing and adult rats","volume":"44","author":"Olson","year":"1972","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2000.7624_RF95","series-title":"Cytoarchitecture of the Human Brain Stem","author":"Olszewski","year":"1954"},{"key":"10.1006\/exnr.2000.7624_RF96","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0014-2999(90)90291-D","article-title":"Striatal and nucleus accumbemns D1\/D2 dopamine receptors in neuroleptic catalepsy","volume":"182","author":"Ossowska","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1006\/exnr.2000.7624_RF97","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1136\/jnnp.54.1.30","article-title":"The absolute number of nerve cells in substantia nigra in normal subjects and in Parkinson's disease estimated with an unbiased sterological method","volume":"54","author":"Pakkenberg","year":"1991","journal-title":"J. Neurol. Neurosurg. Psychol."},{"key":"10.1006\/exnr.2000.7624_RF98","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0006-8993(89)90597-0","article-title":"A 6-hydroxydopamine-induced selective parkinsonian rat model","volume":"494","author":"Perese","year":"1989","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2000.7624_RF99","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1021\/jm970099t","article-title":"Iron-mediated generation of the neurotoxin 6-hydroxydopamine quinone by reaction of fatty acid hydroperoxides with dopamine: A possible contributory mechanism for neuronal degeneration in Parkinson's disease","volume":"40","author":"Pezzella","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1006\/exnr.2000.7624_RF100","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0304-3940(88)90066-3","article-title":"The neurotoxin MPTP does not reproduce in the rhesus monkey the inter-regional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease","volume":"92","author":"Pifl","year":"1988","journal-title":"Neurosci. Lett."},{"key":"10.1006\/exnr.2000.7624_RF101","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ana.410440710","article-title":"Autosomal dominant Parkinson's disease and \u03b1-synuclein","volume":"44","author":"Polymeropoulos","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF102","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0306-4522(92)90012-Q","article-title":"Calretinin in the rat brain: An immunohistochemical study","volume":"46","author":"R\u00e9sibois","year":"1992","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2000.7624_RF103","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ana.410440726","article-title":"Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: A target for neuroprotection","volume":"44","author":"Rodr\u0131\u0301guez","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF104","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0006-8993(92)90998-O","article-title":"Immunohistochemical markers in the rat brain: Colocalization of calretinin and calbindin-D28k with tyrosine hydroxylase","volume":"587","author":"Rogers","year":"1992","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2000.7624_RF105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0166-2236(87)90177-9","article-title":"Exitotoxicity and NMDA receptors","volume":"10","author":"Rothman","year":"1987","journal-title":"Trends Neurosci."},{"key":"10.1006\/exnr.2000.7624_RF106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-2952(75)90304-4","article-title":"Mechanism of action of 6-hydroxydopamine","volume":"24","author":"Sachs","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1006\/exnr.2000.7624_RF107","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0091-3057(95)00164-6","article-title":"Vacuous jaw movements induced by acute reserpine and low-dose apomorphine: Possible model of parkinsonian tremor","volume":"53","author":"Salamone","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1006\/exnr.2000.7624_RF108","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF00178508","article-title":"Behavioral and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat","volume":"88","author":"Salamone","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1006\/exnr.2000.7624_RF109","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1037\/0735-7044.102.5.748","article-title":"The catalepsy test: its ups and downs","volume":"102","author":"Sanberg","year":"1988","journal-title":"Behav. Neurosci."},{"key":"10.1006\/exnr.2000.7624_RF110","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","article-title":"Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxudopamine: A combined retrograde tracing and immunocytochemical study in the rat","volume":"59","author":"Sauer","year":"1994","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2000.7624_RF111","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.2000.7624_RF112","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0014-2999(74)90040-5","article-title":"Effect of 6-hydroxydopamine on some actions of tremorine and oxotremorine","volume":"25","author":"Slater","year":"1974","journal-title":"Eur. J. Pharmacol."},{"key":"10.1006\/exnr.2000.7624_RF113","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0006-8993(97)01128-1","article-title":"Cross-sensitization between footschock stress and apomorphine on self-injurious behavior and neostriatal catecholamines in a rat model of Lesch-Nyhan syndrome","volume":"783","author":"Stodgell","year":"1998","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2000.7624_RF114","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0361-9230(82)90145-9","article-title":"The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluorescence study in the rat","volume":"9","author":"Swanson","year":"1982","journal-title":"Brain Res. Bull."},{"key":"10.1006\/exnr.2000.7624_RF115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cne.901890207","article-title":"Organization of the ascending striatal afferents in monkeys","volume":"189","author":"Szabo","year":"1980","journal-title":"J. Comp. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF116","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0006-8993(88)90315-0","article-title":"MPTP produces a pattern of nigrostriatal degeneration which coincides with mosaic organization of the caudate nucleus","volume":"473","author":"Turner","year":"1988","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2000.7624_RF117","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1212\/WNL.35.8.1215","article-title":"Parkinson's disease: Loss of neurons from the ventral tegmental area contralateral to therapeutic surgical lesions","volume":"35","author":"Uhl","year":"1985","journal-title":"Neurology"},{"key":"10.1006\/exnr.2000.7624_RF118","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","article-title":"Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system","volume":"24","author":"Ungerstedt","year":"1970","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2000.7624_RF119","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-201X.1971.tb10999.x","article-title":"Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behavior","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"10.1006\/exnr.2000.7624_RF120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","article-title":"Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"10.1006\/exnr.2000.7624_RF121","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-201X.1971.tb11001.x","article-title":"Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"10.1006\/exnr.2000.7624_RF122","first-page":"157","article-title":"Effect of L-DOPA on the locomotor activity of rats pretreated with 6-hydroxydopamine","volume":"234","author":"Uretsky","year":"1971","journal-title":"Nature"},{"key":"10.1006\/exnr.2000.7624_RF123","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/0306-4522(80)90198-0","article-title":"The topical organization of the afferents to the caudadoputamen of the rat: A horseradish peroxidase study","volume":"5","author":"Veening","year":"1980","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2000.7624_RF124","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0306-4522(94)90566-5","article-title":"Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis","volume":"63","author":"Walkinshaw","year":"1994","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2000.7624_RF125","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0006-8993(87)90857-2","article-title":"MPTP produces a mosaic-like pattern of terminal degeneration in the caudate nucleus of dog","volume":"423","author":"Wilson","year":"1987","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2000.7624_RF126","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ana.410440709","article-title":"Genetic risk factors in Parkinson's disease","volume":"44","author":"Wood","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.2000.7624_RF127","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-8993(90)91236-A","article-title":"Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28k","volume":"526","author":"Yamada","year":"1990","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2000.7624_RF128","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1126\/science.182.4113.717","article-title":"Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hipothalamic lesions","volume":"182","author":"Zigmond","year":"1973","journal-title":"Science"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488600976246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488600976246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T04:41:02Z","timestamp":1620016862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488600976246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":128,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["S0014488600976246"],"URL":"https:\/\/doi.org\/10.1006\/exnr.2000.7624","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}